Structure and Bioactivity of Neuropeptide F from the Human Parasites Schistosoma mansoni and Schistosoma japonicum*

The blood flukes Schistosoma mansoni and Schistosoma japonicum inflict immense suffering as agents of human schistosomiasis. Previous investigations have found the nervous systems of these worms contain abundant immunoreactivity to antisera targeting invertebrate neuropeptide Fs (NPFs) as well as structurally similar neuropeptides of the mammalian neuropeptide Y (NPY) family. Here, cDNAs encoding NPF in these worms were identified, and the mature neuropeptides from the two species differed by only a single amino acid. Both neuropeptides feature the characteristics common among NPFs; they are 36 amino acids long with a carboxyl-terminal Gly-Arg-X-Arg-Phe-amide and Tyr residues at positions 10 and 17 from the carboxyl terminus. Synthetic S. mansoni NPF potently inhibits the forskolin-stimulated accumulation of cAMP in worm homogenates, with significant effects at 10-11 m. This is the first demonstration of an endogenous inhibition of cAMP by an NPF, and because this is the predominant pathway associated with vertebrate NPY family peptides, it demonstrates a conservation of downstream signaling pathways used by NPFs and NPY peptides.

[1]  I. Fairweather,et al.  Immunoreactivity to the pancreatic polypeptide family in the nervous system of the adult human blood fluke, Schistosoma mansoni , 1990, Cell and Tissue Research.

[2]  D. Littlewood,et al.  Phylogeny and classification of the Digenea (Platyhelminthes: Trematoda). , 2003, International journal for parasitology.

[3]  T. Day,et al.  Gene organization and expression of a neuropeptide Y homolog from the land planarian Arthurdendyus triangulatus , 2002, The Journal of comparative neurology.

[4]  Fabio Zicker,et al.  Strategic emphases for tropical diseases research: a TDR perspective. , 2002, Trends in parasitology.

[5]  T. F. Murray,et al.  Characterization of a functional neuropeptide F receptor from Drosophila melanogaster , 2002, Peptides.

[6]  M. Matz.  Amplification of representative cDNA samples from microscopic amounts of invertebrate tissue to search for new genes. , 2002, Methods in molecular biology.

[7]  S. D. de Vlas,et al.  Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence , 2001, Tropical medicine & international health : TM & IH.

[8]  T. Day,et al.  Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. , 2001, International journal for parasitology.

[9]  T. Day,et al.  Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections , 2001, Parasitology.

[10]  A. Maule,et al.  The neuropeptide F (NPF) encoding gene from the cestode, Moniezia expansa , 2000, Parasitology.

[11]  T. Day,et al.  Parasitic peptides! The structure and function of neuropeptides in parasitic worms , 1999, Peptides.

[12]  T. Day,et al.  Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. , 1999, The American journal of tropical medicine and hygiene.

[13]  R. Leurs,et al.  Molecular cloning and characterization of an invertebrate homologue of a neuropeptide Y receptor , 1998, The European journal of neuroscience.

[14]  H Herzog,et al.  XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. , 1998, Pharmacological reviews.

[15]  A. Balasubramaniam.  Neuropeptide Y Family of Hormones: Receptor Subtypes and Antagonists , 1997, Peptides.

[16]  T. Day,et al.  The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug praziquantel. , 1997, Experimental parasitology.

[17]  D. Larhammar.  Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide , 1996, Regulatory Peptides.

[18]  D. Larhammar.  Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide , 1996, Regulatory Peptides.

[19]  G. Brennan,et al.  Localisation, quantitation, and characterisation of neuropeptide F‐ and FMRFamide‐immunoreactive peptides in turbellarians and a monogenean: A comparative study , 1995, The Journal of comparative neurology.

[20]  G. Brennan,et al.  Comparative analyses of the neuropeptide F (NPF)- and FMRFamide-related peptide (FaRP)-immunoreactivities in Fasciola hepatica and Schistosoma spp , 1995, Parasitology.

[21]  I. Fairweather,et al.  Light and electron microscopic immunocytochemistry of FMRFamide and neuropeptide F immunoreactivities in the human blood fluke, Schistosoma mansoni. , 1995, Acta biologica Hungarica.

[22]  T. Day,et al.  Praziquantel: The enigmatic antiparasitic. , 1992, Parasitology today.

[23]  L. Thim,et al.  The primary structure of neuropeptide F (NPF) from the garden snail, Helix aspersa , 1992, Regulatory Peptides.

[24]  I. Fairweather,et al.  Neuropeptide F: a novel parasitic flatworm regulatory peptide from Moniezia expansa (Cestoda: Cyclophyllidea) , 1991, Parasitology.

[25]  M. Michel.  Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. , 1991, Trends in pharmacological sciences.

[26]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[27]  I. Fairweather,et al.  A confocal scanning laser microscope study of the peptidergic and serotoninergic components of the nervous system in larval Schistosoma mansoni , 1990, Parasitology.

[28]  T. Schwartz,et al.  Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase , 1990, FEBS letters.

[29]  Y. Shigeri,et al.  Neuropeptide Y‐induced intracellular Ca2+ increases in vascular smooth muscle cells , 1989, FEBS letters.

[30]  T. Mansour,et al.  Nature of serotonin-activated adenylate cyclase during development of Schistosoma mansoni. , 1987, Molecular and biochemical parasitology.

[31]  J. M. Mansour,et al.  GTP-binding proteins associated with serotonin-activated adenylate cyclase in Fasciola hepatica. , 1986, Molecular and biochemical parasitology.

[32]  B. Fredholm,et al.  Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. , 1985, Acta physiologica Scandinavica.

[33]  J. Richards,et al.  Adenosine 3',5'-monophosphate, luteinizing hormone receptor, and progesterone during granulosa cell differentiation: effects of estradiol and follicle-stimulating hormone. , 1979, Endocrinology.